Rossari Biotech Ltd | Industry : (Chemicals) | |
---|---|---|
BSE Code : 543213 |
NSE Symbol : ROSSARI |
P/E(TTM) : 49.35 |
ISIN Demat : INE02A801020 |
Div & Yield% : 0.05 |
EPS(TTM) : 18.52 |
Book Value(₹) : 173.70 |
Market Cap(₹Cr) : 5,053.44 |
Face Value(₹) : 2.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 300.71 | 313.80 | 298.75 | 332.01 | 258.34 | 263.64 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 300.71 | 313.80 | 298.75 | 332.01 | 258.34 | 263.64 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 1.26 | 1.34 | 2.13 | 1.96 | 1.34 | 2.32 |
Total Income | 301.97 | 315.15 | 300.88 | 333.98 | 259.68 | 265.96 |
Total Expenditure | 260.90 | 272.08 | 257.61 | 289.67 | 223.21 | 227.85 |
PBIDT | 41.06 | 43.06 | 43.27 | 44.30 | 36.47 | 38.11 |
Interest | 2.33 | 1.74 | 2.63 | 2.54 | 1.88 | 1.16 |
PBDT | 38.74 | 41.33 | 40.64 | 41.76 | 34.60 | 36.95 |
Depreciation | 6.06 | 6.58 | 5.84 | 6.26 | 5.51 | 6.72 |
Tax | 8.53 | 8.41 | 10.32 | 9.58 | 7.86 | 8.02 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -0.18 | 0.17 | -1.06 | -0.46 | -0.33 | -0.93 |
Reported Profit After Tax | 24.33 | 26.17 | 25.54 | 26.38 | 21.56 | 23.14 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 24.33 | 26.17 | 25.54 | 26.38 | 21.56 | 23.14 |
EPS (Unit Curr.) | 4.40 | 4.74 | 4.62 | 4.78 | 3.91 | 4.20 |
EPS (Adj) (Unit Curr.) | 4.40 | 4.74 | 4.62 | 4.78 | 3.91 | 4.20 |
Calculated EPS (Unit Curr.) | 4.40 | 4.74 | 4.62 | 4.78 | 3.91 | 4.20 |
Calculated EPS (Adj) (Unit Curr.) | 4.40 | 4.74 | 4.62 | 4.78 | 3.91 | 4.20 |
Calculated EPS (Ann.) (Unit Curr.) | 17.61 | 18.95 | 18.50 | 19.11 | 15.63 | 16.78 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 17.61 | 18.95 | 18.50 | 19.11 | 15.63 | 16.78 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 11.05 | 11.05 | 11.05 | 11.05 | 11.03 | 11.03 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 13.65 | 13.72 | 14.48 | 13.34 | 14.12 | 14.46 |
PBDTM(%) | 12.88 | 13.17 | 13.60 | 12.58 | 13.39 | 14.02 |
PATM(%) | 8.09 | 8.34 | 8.55 | 7.95 | 8.35 | 8.78 |